Risk factors associated with bloodstream infections in end-stage renal disease patients: a population-based study

Infectious Diseases
Gabrielle DagassoK B Laupland

Abstract

Bloodstream infections (BSI) commonly complicate end-stage renal disease (ESRD) and are the second most common cause of death in these patients. The objective of this study was to define risk factors for development of BSI and its outcome among ESRD patients. A retrospective, population-based, matched cohort design was utilized. All adult (18 or older) residents of the western interior of British Columbia with ESRD who had a first BSI between April 2010 and March 2017 were included. Subject cases were then matched 1:1 with an ESRD patient from the regional registry who did not have a BSI. During the study period a total of 53 cases of incident BSI were identified among patients with ESRD. The median age was 70.7 (interquartile range, 61.9-79.6) years and 28 (53%) were male. The most common organism isolated was Staphylococcus aureus (17 cases; 32%). Compared to controls, case patients were significantly (p < .05) more likely to have higher Charlson comorbidity scores (mean difference (MD): 1.4; 95% CI (0.5, 2.2)), and have lower serum albumin (MD: -3.3; 95% CI (-5.5, -1.2)). Diabetes was not significant; however, cases were twice as likely to be diabetic (OR: 2.0; 95% CI (0.9, 4.8)). Case fatality rates for 30- and 90-days were...Continue Reading

References

Apr 26, 2007·Nature Clinical Practice. Nephrology·Ratnaja Katneni, S Susan Hedayati
Jul 28, 2007·Journal of the American Society of Nephrology : JASN·Robert N Foley, Allan J Collins
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Nabeel AslamBeth Piraino
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mette SøgaardHenrik Carl Schønheyder
May 12, 2012·Internal Medicine·I-Kuan WangJin-Hua Chen
Mar 12, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Goto, M N Al-Hasan
Aug 24, 2013·Revista Da Sociedade Brasileira De Medicina Tropical·Tamara Trelha GaunaMarilene Rodrigues Chang
Oct 24, 2013·International Journal of Medical Sciences·Maria FysarakiDiamantis P Kofteridis
Dec 18, 2013·Seminars in Dialysis·Julie H Ishida, Kirsten L Johansen
Mar 15, 2015·BMJ Open Diabetes Research & Care·Johan R SimonsenUNKNOWN FinnDiane Study Group
Sep 30, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Julie H IshidaKirsten L Johansen
Mar 22, 2016·Epidemiology and Infection·K B LauplandL Steele
May 5, 2016·International Journal of Nephrology and Renovascular Disease·Vivek SoiJerry Yee
May 6, 2016·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Lars Skov DalgaardOle Schmeltz Søgaard
May 7, 2016·Canadian Journal of Kidney Health and Disease·Chris LataMatthew T James
May 26, 2017·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Anitha PadmanabhanPrerna Sachdeva

❮ Previous
Next ❯

Citations

May 19, 2020·Epidemiology and Infection·Gabrielle DagassoKevin B Laupland
Jul 25, 2019·International Journal of Molecular Sciences·Mineaki KitamuraHideki Sakai
Dec 21, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Kevin B LauplandHenrik C Schonheyder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.